The Ataxia Charlevoix-Saguenay Foundation is proud to announce an investment of $1 million in 11 promising ARSACS research projects for 2026–2027. This significant commitment advances our shared mission to deepen our understanding of ARSACS and accelerate the development of effective therapies. We extend our sincere gratitude to the Richardson Trust Fund and the Action for ARSACS Foundation USA (AFA) for their contributions in jointly funding ARSACS research with the Foundation.
Congratulations to the dedicated researchers whose projects have been selected for funding. Your innovation and commitment continue to advance scientific knowledge.